Literature DB >> 9735234

In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets.

F Wang1, J Larsson, T E Adrian, T Gasslander, J Permert.   

Abstract

BACKGROUND: Interactions have been found between exocrine pancreatic adenocarcinoma and islets of Langerhans. Growth of pancreatic adenocarcinoma cells can be regulated by islet hormones such as insulin and somatostatin. Conversely, dysfunction of endocrine pancreas frequently accompanies the exocrine malignancy. The mechanisms underlying these interactions have not been defined.
MATERIALS AND METHODS: Human pancreatic adenocarcinoma cells (HPAF cells) were cocultured with isolated rat pancreatic islets in two-compartment wells. HPAF cells and islets cultured in separate wells served as controls. In separate experiments, HPAF cells were incubated with two concentrations of exogenous insulin, including one reflecting the levels of insulin secretion seen in the coculture experiments.
RESULTS: Proliferation of HPAF cells was increased by about 50% following a 2- or 5-day incubation with pancreatic islets (P < 0.05). Coculture of HPAF cells and pancreatic islets was associated with a greater reduction in glucose concentrations (P < 0. 01) and an increase in lactate accumulation (P < 0.05) in the culture media. Insulin concentrations in the media were significantly decreased during the first 2-3 days of the coculture incubation (P < 0.05). In contrast, insulin secretion from control islets was not significantly decreased until the fifth day of the experiment. The growth of HPAF cells was stimulated by both concentrations of exogenous insulin (P < 0.05). The insulin-stimulated HPAF cells also showed an enhanced glucose consumption and lactate production (P < 0.05).
CONCLUSIONS: Pancreatic islets regulate both growth and glucose metabolism of adjacent exocrine cancer cells. beta-cell-derived insulin may be one of the factors inducing these effects. Insulin release from islet beta-cells is compromised in the presence of exocrine cancer cells. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735234     DOI: 10.1006/jsre.1998.5393

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  12 in total

1.  Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis.

Authors:  Feng Wang; Shu Shun Li; Ralf Segersvärd; Lisa Strömmer; Karl-Gösta Sundqvist; Jan Holgersson; Johan Permert
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

3.  Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age.

Authors:  Suguru Mizuno; Yousuke Nakai; Hiroyuki Isayama; Ayako Yanai; Naminatsu Takahara; Koji Miyabayashi; Keisuke Yamamoto; Kazumichi Kawakubo; Dai Mohri; Hirofumi Kogure; Takashi Sasaki; Natsuyo Yamamoto; Naoki Sasahira; Kenji Hirano; Takeshi Tsujino; Hideaki Ijichi; Keisuke Tateishi; Masao Akanuma; Minoru Tada; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-06-28       Impact factor: 7.527

4.  Insulin and hypoxia-inducible factor-1 cooperate in pancreatic cancer cells to increase cell viability.

Authors:  Dapeng Zhang; Lihua Cui; Shu Shun Li; Feng Wang
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

Review 5.  The early diagnosis of pancreatic cancer and diabetes: what's the relationship?

Authors:  Changsong Zhang; Guangshun Yang; Yang Ling; Guihua Chen; Tianbao Zhou
Journal:  J Gastrointest Oncol       Date:  2014-12

Review 6.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.

Authors:  Rahul Pannala; Ananda Basu; Gloria M Petersen; Suresh T Chari
Journal:  Lancet Oncol       Date:  2009-01       Impact factor: 41.316

7.  Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus.

Authors:  Rahul Pannala; Jeffery B Leirness; William R Bamlet; Ananda Basu; Gloria M Petersen; Suresh T Chari
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

8.  Research on the relationships between pancreatic cancer and hyperglycemia in Chinese populations.

Authors:  Shan Huang; Hongying Ye; Wei Wu; Cheng Chen; Ji Li; Deliang Fu; Yiming Li
Journal:  J Diabetes Investig       Date:  2012-08-30       Impact factor: 4.232

Review 9.  The relationship between diabetes and pancreatic cancer.

Authors:  Feng Wang; Margery Herrington; Jörgen Larsson; Johan Permert
Journal:  Mol Cancer       Date:  2003-01-06       Impact factor: 27.401

10.  Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.

Authors:  B M Wolpin; D S Michaud; E L Giovannucci; E S Schernhammer; M J Stampfer; J E Manson; B B Cochrane; T E Rohan; J Ma; M N Pollak; C S Fuchs
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.